Federal Pharmaceutical (03933.HK): Injectable TUL108 granted implied approval for clinical trials of new drugs in China.

Wisdom Financial APP News, Federal Pharmaceutical (03933.HK) announced that its wholly-owned subsidiary, Zhuhai Federal Pharmaceuticals Co., Ltd., has obtained the implied approval for clinical trial of the innovative drug injection TUL108 independently developed by the company from the National Medical Products Administration of China, with acceptance number CXHL2600206.